845264-90-6Relevant articles and documents
4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives
-
Paragraph 0745; 0774, (2015/01/06)
The invention relates to compounds of Formula (I) wherein ring A, X, (R1)n, R2, R3, R4, R4′, R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES
-
Page/Page column 97; 98; 104, (2013/08/15)
The invention relates to compounds of Formula (I) wherein ring A, X, (R1)n, R2, R3, R4, R4', R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4- dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Zhang, Jing,Zhan, Peng,Wu, Jingde,Li, Zhenyu,Jiang, Yan,Ge, Weiying,Pannecouque, Christophe,De Clercq, Erik,Liu, Xinyong
scheme or table, p. 4366 - 4376 (2011/08/09)
A series of novel S-DABO analogues of 5-alkyl-2-arylthio-6-((3,4- dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones were synthesized and evaluated as inhibitors of human immunodeficiency virus type-1 (HIV-1). Among them, the most potent HIV-1 inhibitor